RealPharma: Conversations with Pharma Pathfinders

Episode Title: Paging Dr. ChaptGPT with Bryce Sady

AI Adoption in Healthcare: Navigating the Present and Shaping the Future with Bryce Sady

Episode Description: On today's insightful episode of RealPharma, hosts Dr. Na-Ri Oh and Ian Wendt sit down with Bryce Sady, Vice President of Product Development at PSL Group's Medical Education and Communications Division, a veteran innovator at the intersection of healthcare data, educatio...

Episode Title: “Hiring Heat Check: What’s Hot in Biotech + Pharma Talent in Mid-2025”

🎙️ Hosts: Ian Wendt & Na-Ri Oh 🎧 Guest: Kristiaan Rawlings, Executive Recruiter at EPM Scientific

Episode Overview:

This week, fan favorite Kristiaan Rawlings returns to RealPharma to give us the raw and real insights on pharma and biotech hiring trends as we hit the midpoint of 2025. From compensation curves and BD boom times to the rise...

Guest: Andrew Craig, Founder of Plain English Finance | Author of Our Future is Biotech

In this bold and wide-ranging conversation, Ian Wendt and Na-Ri Oh sit down with Andrew Craig—British investor, entrepreneur, and author—to explore how biotechnology is poised to shape the next century in the same way physics and computing shaped the last.

Craig draws on his decades ...

🎙 Episode Title: Rooted in Results: The Future of Functional Medicine with Dr. Erica Armstrong 

🧬 Episode Summary In this episode, Dr. Na-Ri Oh and Ian Wendt sit down with Dr. Erica Armstrong, board-certified family medicine physician and founder of Root Functional Medicine, to explore the promise, challenges, and evolution of functional medicine. Dr. Armstrong discusses how Root’s systems-based, data-driven approach is helpi...

🎙️ RealPharma Podcast

Episode Title: Cracking the Code on Patient Engagement: Conversational AI with Dan Fox

🗓️ Release Date: May 5, 2025 🎧 Hosts: Dr. Na-Ri Oh & Ian Wendt 🎤 Guest: Dan Fox, Managing Director of Healthcare at Drips

In this eye-opening episode, we welcome Dan Fox, a trailblazer in AI-powered patient communication, to explore how proactive outreach and conversational AI are reshaping healthca...

In this powerful and deeply human episode of RealPharma, we’re joined by Grace Magedman, PharmD—former Chief Pharmacy Officer at Children’s Hospital of Orange County, functional medicine practitioner, and founder of The Magidman Group.

Grace takes us inside her 20+ years of hospital pharmacy leadership, where she navigated high-stakes medication decisions, complex implementation of rare disease therapies, and the ethical strain of ...

In this second part of our deep dive into hematology and oncology, we welcome back Dr. Yaming Wang, founder of Alphabet Health LTD and an expert in molecular oncology, pharmaceutical strategy, and medical education. Building on our previous discussion, we explore cutting-edge advancements in cancer diagnostics and therapies, including the promise and limitations of liquid biopsies, the evolution of immunotherapy, and the expanding ...

🎙 RealPharma Podcast – Oncology Part 1: Understanding the Cancer Universe with Dr. Yaming Wang

Cancer is one of the most complex and pressing challenges in modern medicine. But how much do we really understand about it? In this first episode of our two-part oncology deep dive, we sit down with Dr. Yaming Wang, founder of Alphabet Health, to break down the fundamentals of oncology and hematology.

From the earliest discoveries in ca...

In this episode of Real Pharma, hosts Na-Ri Oh and Ian Wendt engage with Joshua Kettner, co-founder of DreamBody Clinic, to explore the intricacies of stem cell therapy.

They discuss the clinic's unique approach to regenerative medicine, the science behind mesenchymal stem cells, and the various applications and limitations of this therapy. The conversation also delves into the regulatory challenges faced in the US and how these im...

In this riveting episode of RealPharma, hosts Na-Ri Oh and Ian Wendt sit down with the renowned ethnopharmacologist, Dennis McKenna, to explore the profound intersection of nature, science, and healing. From Dennis’s storied journey into the world of plant medicines to the evolving landscape of psychedelic therapies, this conversation is as thought-provoking as it is inspiring.

Key Topics Discussed:

🌿 Dennis’s Journey: How an ea...

In this episode of the Real Pharma Podcast, hosts Ian Wendt and Na-Ri Oh welcome back frequent guest Kristiaan Rawlings, a seasoned commercial pharmaceutical recruiter, for a year-end reflection on the pharmaceutical job market in 2024 and a look ahead to 2025. The discussion highlights key trends, challenges, and opportunities for candidates and employers alike.

• Job Market...

In this episode of the Real Pharma Podcast, hosts Ian Wendt and Dr. Na-Ri Oh and guest Jason Scharf delve into the evolving landscape of TechBio, exploring its definition, the rise of bio innovation, and the challenges and opportunities it presents.

They discuss the shift from traditional drug development methods to innovative approaches driven by technology, the importance of adapting business models in the pharmaceutical industry...

In this conversation, Roger Estafanos discusses the evolving field of radiopharmaceuticals, highlighting their transformative impact on cancer treatment and patient care.

He explains the targeted nature of these therapies, the importance of personalized medicine, and the challenges faced in regulatory processes and patient safety. The discussion also covers the role of different radioisotopes, the complexities of supply chain manag...

In this conversation, Aaron Burnett, from Wheelhouse DMG, discusses the rapid evolution of digital marketing in the healthcare sector, emphasizing the importance of data strategy and compliance with regulations like HIPAA.

He highlights the shift from third-party data reliance to first-party data utilization, which enhances marketing effectiveness and patient engagement.

The discussion also covers the need for collaboration among m...

In this latest episode of RealPharma, we’re diving back into the fascinating world of AI in pharma, breaking down all the insights from our conversation with the brilliant Andree Bates! If you missed it or want to catch the highlights, this episode serves up a concise, punchy summary covering everything from predictive analytics to patient outcomes and beyond.

But there's a twist.

Our hosts, this time, bring a unique, fresh perspec...

In this episode, Dr. Na-Ri Oh and Ian Wendt sit down with Philip Vyt, a renowned expert in omnichannel strategy and founder of Shyft, a consultancy specializing in omnichannel approaches for biopharma.

They delve into the key concepts behind omnichannel and its distinction from multichannel, emphasizing the centrality of healthcare professionals (HCPs) in engagement strategies. Philip breaks down the importance of personalized cont...

In this episode, Dr. Na-Ri and Ian Wendt welcome back Kristiaan Rawlings, from EPM Scientific to discuss the latest trends in pharma and biotech hiring.

They explore the key drivers of hiring, the impact of AI and advanced analytics, and the evolving expectations of candidates. Kristiaan emphasizes the importance of change agents in the industry and shares insights on the optimistic outlook for small biotechs and oncology. The conv...

In this episode, Ian Wendt and Dr. Na-Ri Oh interview Michael C. Barnes, Chairman of the Center for US Policy, about the US opioid crisis.

They discuss the evolution of US policy on opioids, the impact of the crisis on different communities, the role of legislation and harm reduction, the accountability of the pharmaceutical industry, barriers to accessing treatment, and the importance of advocacy in addressing stigma.

The conversa...

Danny McBryan, an executive leader in the pharmaceutical industry, discusses the evolving role of medical affairs in healthcare.

He highlights the importance of medical affairs in conveying the science of pharmaceutical companies and translating complex data into a meaningful narrative for healthcare providers, payers, patients, and policymakers.

McBryan emphasizes the need for medical affairs to be seen as a strategic partner rath...